AT337183B - Verfahren zur herstellung von neuen 1-(imidazol-1-yl)-isochinolinen und ihren salzen - Google Patents

Verfahren zur herstellung von neuen 1-(imidazol-1-yl)-isochinolinen und ihren salzen

Info

Publication number
AT337183B
AT337183B AT245274A AT245274A AT337183B AT 337183 B AT337183 B AT 337183B AT 245274 A AT245274 A AT 245274A AT 245274 A AT245274 A AT 245274A AT 337183 B AT337183 B AT 337183B
Authority
AT
Austria
Prior art keywords
isochinolines
imidazol
salt
preparation
new
Prior art date
Application number
AT245274A
Other languages
English (en)
Other versions
ATA245274A (de
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ATA245274A publication Critical patent/ATA245274A/de
Application granted granted Critical
Publication of AT337183B publication Critical patent/AT337183B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT245274A 1973-03-26 1974-03-25 Verfahren zur herstellung von neuen 1-(imidazol-1-yl)-isochinolinen und ihren salzen AT337183B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732314985 DE2314985A1 (de) 1973-03-26 1973-03-26 1-(imidazol-1-yl)-isochinoline und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ATA245274A ATA245274A (de) 1976-10-15
AT337183B true AT337183B (de) 1977-06-10

Family

ID=5875934

Family Applications (1)

Application Number Title Priority Date Filing Date
AT245274A AT337183B (de) 1973-03-26 1974-03-25 Verfahren zur herstellung von neuen 1-(imidazol-1-yl)-isochinolinen und ihren salzen

Country Status (13)

Country Link
US (1) US3914236A (de)
JP (1) JPS49126684A (de)
AT (1) AT337183B (de)
BE (1) BE812841A (de)
DD (1) DD114607A5 (de)
DE (1) DE2314985A1 (de)
ES (1) ES424436A1 (de)
FR (1) FR2223024B1 (de)
GB (1) GB1464289A (de)
HU (1) HU168524B (de)
IL (1) IL44478A (de)
NL (1) NL7403829A (de)
ZA (1) ZA741917B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54151990A (en) * 1978-04-17 1979-11-29 Beiersdorf Ag Novel condensated nitrogenncontained heterocyclic compound and its manufacture
US5716972A (en) * 1993-01-13 1998-02-10 Smithkline Beecham Corporation Pyridyl substituted imidazoles
DE4215587A1 (de) * 1992-05-12 1993-11-18 Bayer Ag Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone
US5446071A (en) * 1994-11-18 1995-08-29 Eli Lilly And Company Methods for lowering serum cholesterol
US6340759B1 (en) 1997-10-02 2002-01-22 Eisai Co., Ltd. Fused pyridine derivatives
EP1613604B1 (de) * 2003-04-16 2006-07-05 Huntsman Advanced Materials (Switzerland) GmbH 1-imidazolylmethyl-substituirte-2-naphtol unh ihre verwendung als niedertemperatur-härtungsbeschleuniger

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH485736A (de) * 1967-04-26 1970-02-15 Agripat Sa Verfahren zur Herstellung halogensubstituierter Imidazol-Derivate
GB1170188A (en) * 1967-09-15 1969-11-12 Bayer Ag N-trityl-imidazoles and salts and uses thereof
DE1964996C3 (de) * 1969-12-24 1978-11-30 Bayer Ag, 5090 Leverkusen 9-Azolyl-fluoren-9-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel zur Regulierung des Pflanzenwachstums
FR2076625A5 (de) * 1970-01-21 1971-10-15 Rhone Poulenc Sa

Also Published As

Publication number Publication date
FR2223024A1 (de) 1974-10-25
ES424436A1 (es) 1977-05-16
DD114607A5 (de) 1975-08-12
IL44478A0 (en) 1974-06-30
ZA741917B (en) 1975-03-26
GB1464289A (en) 1977-02-09
DE2314985A1 (de) 1974-10-17
HU168524B (de) 1976-05-28
JPS49126684A (de) 1974-12-04
ATA245274A (de) 1976-10-15
AU6709874A (en) 1975-09-25
IL44478A (en) 1977-07-31
BE812841A (fr) 1974-09-26
US3914236A (en) 1975-10-21
FR2223024B1 (de) 1978-01-06
NL7403829A (de) 1974-09-30

Similar Documents

Publication Publication Date Title
AT336029B (de) Verfahren zur herstellung von neuen imidazotriazinen und ihren salzen
AT341518B (de) Verfahren zur herstellung von neuen imidazolderivaten und ihren salzen
AT330180B (de) Verfahren zur herstellung von neuen benzo-(ij)-chinolizinderivaten und ihren salzen
AT336604B (de) Verfahren zur herstellung von neuen triazolopyridazinen und ihren salzen
AT333296B (de) Verfahren zur herstellung von neuen 7-fluor-substituierten phenthiazinen, ihren salzen und ihren piperazin-n-oxyden
AT351538B (de) Verfahren zur herstellung von neuen hydratropasaeure-derivaten und ihren salzen
AT334370B (de) Verfahren zur herstellung von neuen triazoloisoindolderivaten und ihren salzen
AT333271B (de) Verfahren zur herstellung von neuen 2-(phenoxyalkylthio)-imidazolen und ihren salzen
AT337191B (de) Verfahren zur herstellung von neuen 3,4-dihydro-2h-naphthalinon-(1)-5-oxy-propyl-piperazin-derivate und ihren salzen
AT337183B (de) Verfahren zur herstellung von neuen 1-(imidazol-1-yl)-isochinolinen und ihren salzen
AT338274B (de) Verfahren zur herstellung von neuen n-substituierten 1-amino-3-phenoxy-propanolen-(2) und ihren salzen
AT332425B (de) Verfahren zur herstellung von neuen 6-aminouracilen und ihren salzen
AT332547B (de) Verfahren zur herstellung von neuen aminoglykosiden und ihren salzen
AT333748B (de) Verfahren zur herstellung von neuen imidazolderivaten und ihren salzen
AT335447B (de) Verfahren zur herstellung von neuen nitroimidazolderivaten und ihren salzen
AT332874B (de) Verfahren zur herstellung von neuen naphthyridinderivaten und ihren salzen
AT337693B (de) Verfahren zur herstellung von neuen imidazol- und triazolderivaten und ihren salzen
AT336623B (de) Verfahren zur herstellung von neuen triazolobenzodiazepinderivaten und ihren salzen
AT337175B (de) Verfahren zur herstellung von neuen pyrazolon-(5)-derivaten und ihren salzen
ATA57174A (de) Verfahren zur herstellung von neuen imidazolderivaten und ihren salzen
AT342044B (de) Verfahren zur herstellung von neuen 2-carbalkoxy- oder 2-carbaroxy-amino-benzimidazol-5 (6)-phenylathern und ihren salzen
ATA174078A (de) Verfahren zur herstellung von neuen 1- (beta-aryl)-aethyl-1h-1,2,4-triazolketalen und ihren salzen
ATA657076A (de) Verfahren zur herstellung von neuen 2-piperazinyl-thiazol-derivaten und ihren salzen
AT348513B (de) Verfahren zur herstellung von neuen pyrazolon- (5)-derivaten und ihren salzen
AT347934B (de) Verfahren zur herstellung von neuen 1- substituierten pyrazolon-(5)-derivaten und ihren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee